

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.24456696 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.24456696 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 7.24456696 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 7.24456696 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 7.24456696 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.24456696 |
| 7 | microglial cell activation (GO:0001774) | 6.66210036 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.50687727 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 6.05910704 |
| 10 | positive regulation of chemokine secretion (GO:0090197) | 5.03310504 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02779623 |
| 12 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.89538394 |
| 13 | mannose metabolic process (GO:0006013) | 4.82529967 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.80891910 |
| 15 | macrophage activation (GO:0042116) | 4.74139874 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.55316521 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.47488221 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.46536331 |
| 19 | response to host immune response (GO:0052572) | 4.46536331 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.24483012 |
| 21 | response to host (GO:0075136) | 4.24483012 |
| 22 | response to host defenses (GO:0052200) | 4.24483012 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 4.19001819 |
| 24 | virion attachment to host cell (GO:0019062) | 4.18675924 |
| 25 | adhesion of symbiont to host cell (GO:0044650) | 4.18675924 |
| 26 | apoptotic cell clearance (GO:0043277) | 4.17209463 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.09908468 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 4.04627153 |
| 29 | regulation of macrophage chemotaxis (GO:0010758) | 4.01357451 |
| 30 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.01011863 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.96539931 |
| 32 | response to peptidoglycan (GO:0032494) | 3.90768200 |
| 33 | amino sugar catabolic process (GO:0046348) | 3.88624249 |
| 34 | keratan sulfate catabolic process (GO:0042340) | 3.83049583 |
| 35 | adhesion of symbiont to host (GO:0044406) | 3.76609262 |
| 36 | cellular extravasation (GO:0045123) | 3.72575259 |
| 37 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.71841604 |
| 38 | T-helper 1 type immune response (GO:0042088) | 3.70409492 |
| 39 | I-kappaB phosphorylation (GO:0007252) | 3.69353162 |
| 40 | negative regulation of cell killing (GO:0031342) | 3.69055077 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69055077 |
| 42 | regulation of chemokine secretion (GO:0090196) | 3.65306476 |
| 43 | regulation of mononuclear cell migration (GO:0071675) | 3.64343140 |
| 44 | hyaluronan catabolic process (GO:0030214) | 3.61841278 |
| 45 | respiratory burst (GO:0045730) | 3.58846445 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.54413918 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.53788815 |
| 48 | regulation of apoptotic cell clearance (GO:2000425) | 3.52466699 |
| 49 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.52161577 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 3.50725280 |
| 51 | pinocytosis (GO:0006907) | 3.47477945 |
| 52 | negative regulation of interleukin-6 production (GO:0032715) | 3.44332579 |
| 53 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.42921424 |
| 54 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.40046607 |
| 55 | germinal center formation (GO:0002467) | 3.38546445 |
| 56 | adenosine receptor signaling pathway (GO:0001973) | 3.34654103 |
| 57 | N-acetylneuraminate metabolic process (GO:0006054) | 3.34520301 |
| 58 | barbed-end actin filament capping (GO:0051016) | 3.34246441 |
| 59 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.33920770 |
| 60 | detection of molecule of bacterial origin (GO:0032490) | 3.31738514 |
| 61 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.31397314 |
| 62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27282404 |
| 63 | glycosphingolipid catabolic process (GO:0046479) | 3.24400949 |
| 64 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.23750342 |
| 65 | myeloid dendritic cell differentiation (GO:0043011) | 3.21850999 |
| 66 | monocyte chemotaxis (GO:0002548) | 3.17265895 |
| 67 | response to thyroid hormone (GO:0097066) | 3.17110840 |
| 68 | membrane lipid catabolic process (GO:0046466) | 3.16897628 |
| 69 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.15409303 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.13655243 |
| 71 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.13403178 |
| 72 | regulation of integrin activation (GO:0033623) | 3.12726402 |
| 73 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.12534664 |
| 74 | positive regulation of interferon-beta production (GO:0032728) | 3.11242771 |
| 75 | lipoxygenase pathway (GO:0019372) | 3.10367749 |
| 76 | eosinophil chemotaxis (GO:0048245) | 3.09462503 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.08937714 |
| 78 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.07279944 |
| 79 | sphingolipid catabolic process (GO:0030149) | 3.06644538 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 3.06271260 |
| 81 | negative regulation of interleukin-12 production (GO:0032695) | 3.05830400 |
| 82 | regulation of podosome assembly (GO:0071801) | 3.05003208 |
| 83 | regulation of vitamin metabolic process (GO:0030656) | 3.03924039 |
| 84 | positive regulation of heat generation (GO:0031652) | 3.02791093 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02647057 |
| 86 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02151787 |
| 87 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.01393567 |
| 88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99204563 |
| 89 | angiotensin maturation (GO:0002003) | 2.97998376 |
| 90 | regulation of cholesterol storage (GO:0010885) | 2.94690794 |
| 91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93075146 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92553914 |
| 93 | lymphocyte chemotaxis (GO:0048247) | 2.91126352 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.88834496 |
| 95 | regulation of chemokine biosynthetic process (GO:0045073) | 2.88326541 |
| 96 | regulation of fever generation (GO:0031620) | 2.88070117 |
| 97 | regulation of phagocytosis (GO:0050764) | 2.87974190 |
| 98 | glycolipid catabolic process (GO:0019377) | 2.87142532 |
| 99 | phagocytosis, engulfment (GO:0006911) | 2.86248660 |
| 100 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.85744171 |
| 101 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.85358089 |
| 102 | regulation of mast cell degranulation (GO:0043304) | 2.84377351 |
| 103 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.83881351 |
| 104 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.83419235 |
| 105 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.82515934 |
| 106 | detection of external biotic stimulus (GO:0098581) | 2.82283443 |
| 107 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.81608894 |
| 108 | eosinophil migration (GO:0072677) | 2.81071073 |
| 109 | regulation of hypersensitivity (GO:0002883) | 2.77576898 |
| 110 | positive regulation of phagocytosis (GO:0050766) | 2.77260728 |
| 111 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.76781413 |
| 112 | detection of other organism (GO:0098543) | 2.76431318 |
| 113 | positive regulation of cholesterol efflux (GO:0010875) | 2.74842597 |
| 114 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.72681837 |
| 115 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.72286398 |
| 116 | dendritic cell differentiation (GO:0097028) | 2.71932212 |
| 117 | myeloid leukocyte activation (GO:0002274) | 2.71929375 |
| 118 | granulocyte activation (GO:0036230) | 2.71536414 |
| 119 | response to laminar fluid shear stress (GO:0034616) | 2.71025695 |
| 120 | positive regulation of mast cell activation (GO:0033005) | 2.70657819 |
| 121 | cellular response to interferon-gamma (GO:0071346) | 2.69973422 |
| 122 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67835115 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67750956 |
| 124 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.67335778 |
| 125 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.67119646 |
| 126 | * complement activation (GO:0006956) | 2.64821424 |
| 127 | B cell mediated immunity (GO:0019724) | 2.64404695 |
| 128 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.60545352 |
| 129 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60209371 |
| 130 | neutrophil activation (GO:0042119) | 2.60004613 |
| 131 | positive regulation of chemokine production (GO:0032722) | 2.59585480 |
| 132 | detection of bacterium (GO:0016045) | 2.59111556 |
| 133 | cellular response to type I interferon (GO:0071357) | 2.59086283 |
| 134 | type I interferon signaling pathway (GO:0060337) | 2.59086283 |
| 135 | low-density lipoprotein particle clearance (GO:0034383) | 2.57852767 |
| 136 | neutrophil chemotaxis (GO:0030593) | 2.56792092 |
| 137 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.56611823 |
| 138 | adaptation of signaling pathway (GO:0023058) | 2.55587240 |
| 139 | oligosaccharide catabolic process (GO:0009313) | 2.53833170 |
| 140 | macrophage differentiation (GO:0030225) | 2.53830149 |
| 141 | leukotriene metabolic process (GO:0006691) | 2.53374910 |
| 142 | regulation of leukocyte degranulation (GO:0043300) | 2.53215491 |
| 143 | ceramide catabolic process (GO:0046514) | 2.52565236 |
| 144 | positive regulation of lymphocyte migration (GO:2000403) | 2.52132385 |
| 145 | response to cholesterol (GO:0070723) | 2.49574287 |
| 146 | neutrophil migration (GO:1990266) | 2.49102761 |
| 147 | purinergic receptor signaling pathway (GO:0035587) | 2.48568394 |
| 148 | positive regulation of leukocyte degranulation (GO:0043302) | 2.48437489 |
| 149 | negative regulation of interleukin-17 production (GO:0032700) | 2.48143776 |
| 150 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.47734705 |
| 151 | positive regulation of mast cell degranulation (GO:0043306) | 2.46237914 |
| 152 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.46237914 |
| 153 | negative regulation of bone resorption (GO:0045779) | 2.46068513 |
| 154 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.46033623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.03134839 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.39337489 |
| 3 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.71507539 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.31106560 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27606095 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.52983203 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.20066595 |
| 8 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.15102825 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.77805910 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75441785 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.70140334 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49934670 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36792946 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32173524 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31596748 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.29514450 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23069958 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20239580 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13241658 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.06964209 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04701152 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02015582 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.01096125 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92862352 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.89113683 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87697882 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85558779 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83658728 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.76213486 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75799213 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74447589 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72975790 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71332379 |
| 34 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70395498 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64619546 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62977504 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59315489 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59140948 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56559383 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54280472 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54076419 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.52126998 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48641810 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46570598 |
| 45 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44326669 |
| 46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43761466 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41899330 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41663955 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41084303 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40032626 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39465493 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.36901349 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35937714 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33820231 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32688788 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29381810 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28947667 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28347377 |
| 59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28332316 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27832248 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26720035 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23060832 |
| 63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23010500 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22819550 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19740297 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19560817 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17691746 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17606095 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17482180 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16679141 |
| 71 | MYB_26560356_Chip-Seq_TH2_Human | 1.14942488 |
| 72 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13725906 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12646567 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10215587 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09277425 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09140282 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08142866 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08079283 |
| 79 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.07261786 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07032669 |
| 81 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05774712 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05389496 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04789626 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04120652 |
| 85 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02406457 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02166203 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02113632 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01534985 |
| 89 | MYC_22102868_ChIP-Seq_BL_Human | 1.00837180 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00802320 |
| 91 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99020600 |
| 92 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98714738 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98339633 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96594929 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95706075 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94973201 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 0.94633621 |
| 98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94633186 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94131475 |
| 100 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93788546 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93488383 |
| 102 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89908843 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.89726022 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89111780 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89059433 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89008032 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87898355 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87315750 |
| 109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86525285 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85869450 |
| 111 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84632439 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83672984 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80964657 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.80207351 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.74434759 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74400874 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74389750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.24897688 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 4.06590494 |
| 3 | MP0009840_abnormal_foam_cell | 3.94906919 |
| 4 | MP0006082_CNS_inflammation | 3.88309296 |
| 5 | MP0003303_peritoneal_inflammation | 3.39228382 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.34765792 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.32788287 |
| 8 | MP0003436_decreased_susceptibility_to | 3.16469298 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.93564267 |
| 10 | MP0002419_abnormal_innate_immunity | 2.85690519 |
| 11 | MP0003690_abnormal_glial_cell | 2.60910961 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.47825643 |
| 13 | MP0003075_altered_response_to | 2.41037355 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.37928997 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.35194205 |
| 16 | MP0001533_abnormal_skeleton_physiology | 2.23106779 |
| 17 | MP0001790_abnormal_immune_system | 2.22770504 |
| 18 | MP0005387_immune_system_phenotype | 2.22770504 |
| 19 | MP0003724_increased_susceptibility_to | 2.20166458 |
| 20 | MP0005025_abnormal_response_to | 2.20072167 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.12277995 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.09392953 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 2.06231723 |
| 24 | MP0004510_myositis | 1.99302704 |
| 25 | MP0001800_abnormal_humoral_immune | 1.97246071 |
| 26 | MP0000343_altered_response_to | 1.95713723 |
| 27 | MP0005671_abnormal_response_to | 1.93765825 |
| 28 | MP0000604_amyloidosis | 1.88460603 |
| 29 | MP0000685_abnormal_immune_system | 1.87484795 |
| 30 | MP0002723_abnormal_immune_serum | 1.85889327 |
| 31 | MP0009785_altered_susceptibility_to | 1.78370713 |
| 32 | MP0001819_abnormal_immune_cell | 1.65780581 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.63916949 |
| 34 | MP0008469_abnormal_protein_level | 1.63016508 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.60776976 |
| 36 | MP0005451_abnormal_body_composition | 1.54958306 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.54057673 |
| 38 | MP0003329_amyloid_beta_deposits | 1.51285632 |
| 39 | MP0005166_decreased_susceptibility_to | 1.50943376 |
| 40 | MP0002405_respiratory_system_inflammati | 1.47938636 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.47449234 |
| 42 | MP0001851_eye_inflammation | 1.47261048 |
| 43 | MP0004947_skin_inflammation | 1.44611715 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.41685787 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.41270189 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.37962599 |
| 47 | MP0009278_abnormal_bone_marrow | 1.36180777 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.35354670 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.33353172 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.31955290 |
| 51 | MP0005365_abnormal_bile_salt | 1.28514669 |
| 52 | MP0008004_abnormal_stomach_pH | 1.27039497 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.26265869 |
| 54 | MP0001853_heart_inflammation | 1.24924540 |
| 55 | MP0005310_abnormal_salivary_gland | 1.22444489 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.19796741 |
| 57 | MP0005670_abnormal_white_adipose | 1.18009382 |
| 58 | MP0003448_altered_tumor_morphology | 1.17483829 |
| 59 | MP0000716_abnormal_immune_system | 1.16841370 |
| 60 | MP0000249_abnormal_blood_vessel | 1.14118553 |
| 61 | MP0006054_spinal_hemorrhage | 1.10669536 |
| 62 | MP0002090_abnormal_vision | 1.10414042 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.05619374 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.05133774 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.04741117 |
| 66 | MP0002254_reproductive_system_inflammat | 1.03880392 |
| 67 | MP0005390_skeleton_phenotype | 1.03855166 |
| 68 | MP0001542_abnormal_bone_strength | 1.03665006 |
| 69 | MP0003195_calcinosis | 1.03159206 |
| 70 | MP0009764_decreased_sensitivity_to | 1.00772844 |
| 71 | MP0001915_intracranial_hemorrhage | 0.99738198 |
| 72 | MP0000609_abnormal_liver_physiology | 0.99734414 |
| 73 | MP0004130_abnormal_muscle_cell | 0.99662178 |
| 74 | MP0010155_abnormal_intestine_physiology | 0.98918057 |
| 75 | MP0003279_aneurysm | 0.97657206 |
| 76 | MP0009763_increased_sensitivity_to | 0.97512277 |
| 77 | MP0004883_abnormal_blood_vessel | 0.94089300 |
| 78 | MP0002398_abnormal_bone_marrow | 0.94071962 |
| 79 | MP0003252_abnormal_bile_duct | 0.93199962 |
| 80 | MP0002429_abnormal_blood_cell | 0.92191178 |
| 81 | MP0010329_abnormal_lipoprotein_level | 0.91425294 |
| 82 | MP0005023_abnormal_wound_healing | 0.90899925 |
| 83 | MP0008260_abnormal_autophagy | 0.90585831 |
| 84 | MP0002933_joint_inflammation | 0.90005402 |
| 85 | MP0002722_abnormal_immune_system | 0.89837905 |
| 86 | MP0003828_pulmonary_edema | 0.87954382 |
| 87 | MP0001663_abnormal_digestive_system | 0.86870956 |
| 88 | MP0005165_increased_susceptibility_to | 0.86074666 |
| 89 | MP0003045_fibrosis | 0.85659244 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.84980278 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.84545522 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.84545522 |
| 93 | MP0005360_urolithiasis | 0.82388503 |
| 94 | MP0000920_abnormal_myelination | 0.81608719 |
| 95 | MP0005164_abnormal_response_to | 0.81050097 |
| 96 | MP0004019_abnormal_vitamin_homeostasis | 0.80845639 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.79870710 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.77103056 |
| 99 | MP0008873_increased_physiological_sensi | 0.76729899 |
| 100 | MP0003879_abnormal_hair_cell | 0.75970799 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.74606791 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.72668638 |
| 103 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70818211 |
| 104 | MP0005647_abnormal_sex_gland | 0.69823731 |
| 105 | MP0003091_abnormal_cell_migration | 0.69245439 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.68459395 |
| 107 | MP0008874_decreased_physiological_sensi | 0.68304682 |
| 108 | MP0003634_abnormal_glial_cell | 0.67679314 |
| 109 | MP0000598_abnormal_liver_morphology | 0.66216587 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.66180253 |
| 111 | MP0002928_abnormal_bile_duct | 0.65980936 |
| 112 | MP0003633_abnormal_nervous_system | 0.65701752 |
| 113 | MP0002135_abnormal_kidney_morphology | 0.65557925 |
| 114 | MP0005666_abnormal_adipose_tissue | 0.65521536 |
| 115 | MP0003795_abnormal_bone_structure | 0.65087428 |
| 116 | MP0002006_tumorigenesis | 0.64803547 |
| 117 | MP0002118_abnormal_lipid_homeostasis | 0.64719636 |
| 118 | MP0000858_altered_metastatic_potential | 0.64553233 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.63111006 |
| 120 | MP0001849_ear_inflammation | 0.62517841 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.60284613 |
| 122 | MP0002971_abnormal_brown_adipose | 0.59995946 |
| 123 | MP0005319_abnormal_enzyme/_coenzyme | 0.58125162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Systemic lupus erythematosus (HP:0002725) | 9.63408739 |
| 2 | * Glomerulonephritis (HP:0000099) | 6.97669994 |
| 3 | * Complement deficiency (HP:0004431) | 5.86597161 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.85297840 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 5.78779116 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.78779116 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.78779116 |
| 8 | Dysostosis multiplex (HP:0000943) | 5.57101085 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.19205831 |
| 10 | Recurrent abscess formation (HP:0002722) | 5.18581662 |
| 11 | * Abnormality of complement system (HP:0005339) | 5.18373478 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 5.17104746 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 4.63448529 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.42403697 |
| 15 | Mucopolysacchariduria (HP:0008155) | 4.31502216 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.31502216 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.30992274 |
| 18 | Axonal loss (HP:0003447) | 4.10605664 |
| 19 | Disinhibition (HP:0000734) | 4.08223270 |
| 20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.06878913 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.06878913 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.06878913 |
| 23 | * Nephritis (HP:0000123) | 3.79861065 |
| 24 | Cerebral aneurysm (HP:0004944) | 3.62231819 |
| 25 | Mutism (HP:0002300) | 3.62029830 |
| 26 | Nuclear cataract (HP:0100018) | 3.55181633 |
| 27 | Arterial tortuosity (HP:0005116) | 3.42213586 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.37520690 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.35294190 |
| 30 | Retinal atrophy (HP:0001105) | 3.27625132 |
| 31 | Loss of speech (HP:0002371) | 3.25166198 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.23597062 |
| 33 | Hematochezia (HP:0002573) | 3.12981366 |
| 34 | Upper motor neuron abnormality (HP:0002127) | 3.01524841 |
| 35 | Agnosia (HP:0010524) | 2.99955139 |
| 36 | Vascular tortuosity (HP:0004948) | 2.98801224 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.67789767 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.66302220 |
| 39 | Pathologic fracture (HP:0002756) | 2.65068710 |
| 40 | Recurrent skin infections (HP:0001581) | 2.64198114 |
| 41 | Myocardial infarction (HP:0001658) | 2.62020876 |
| 42 | J-shaped sella turcica (HP:0002680) | 2.60195673 |
| 43 | Progressive neurologic deterioration (HP:0002344) | 2.59866513 |
| 44 | Spondylolisthesis (HP:0003302) | 2.59401198 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.56984946 |
| 46 | Thoracic kyphosis (HP:0002942) | 2.56898892 |
| 47 | Optic neuritis (HP:0100653) | 2.55641154 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.55641154 |
| 49 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.55314503 |
| 50 | Malnutrition (HP:0004395) | 2.53443998 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.53407736 |
| 52 | Colitis (HP:0002583) | 2.48674916 |
| 53 | Gingivitis (HP:0000230) | 2.46139414 |
| 54 | Pustule (HP:0200039) | 2.45092360 |
| 55 | Increased serum ferritin (HP:0003281) | 2.42363513 |
| 56 | Amyloidosis (HP:0011034) | 2.41337999 |
| 57 | Abnormality of the lumbar spine (HP:0100712) | 2.40149368 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.31713221 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31117327 |
| 60 | Disproportionate tall stature (HP:0001519) | 2.29486720 |
| 61 | Myositis (HP:0100614) | 2.28287495 |
| 62 | Joint stiffness (HP:0001387) | 2.26509351 |
| 63 | Apathy (HP:0000741) | 2.25743930 |
| 64 | Aortic aneurysm (HP:0004942) | 2.21012795 |
| 65 | Diminished motivation (HP:0000745) | 2.19867265 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.19823069 |
| 67 | Stomatitis (HP:0010280) | 2.18313565 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.17512218 |
| 69 | Striae distensae (HP:0001065) | 2.16518846 |
| 70 | Thick nail (HP:0001805) | 2.15757607 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15720024 |
| 72 | Obstructive lung disease (HP:0006536) | 2.15720024 |
| 73 | Peripheral demyelination (HP:0011096) | 2.14496215 |
| 74 | Metaphyseal irregularity (HP:0003025) | 2.12541400 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.11579729 |
| 76 | Hemoptysis (HP:0002105) | 2.11088870 |
| 77 | Inappropriate behavior (HP:0000719) | 2.10047521 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 2.07787859 |
| 79 | Neurofibrillary tangles (HP:0002185) | 2.05537460 |
| 80 | Abnormality of the nasal mucosa (HP:0000433) | 2.04853966 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.03643852 |
| 82 | Prolonged neonatal jaundice (HP:0006579) | 2.03399962 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.03018611 |
| 84 | Joint hemorrhage (HP:0005261) | 2.02540727 |
| 85 | Petechiae (HP:0000967) | 2.02437822 |
| 86 | Aortic dissection (HP:0002647) | 2.01707359 |
| 87 | Polygenic inheritance (HP:0010982) | 2.00763736 |
| 88 | Ovoid vertebral bodies (HP:0003300) | 1.99603383 |
| 89 | Cardiomegaly (HP:0001640) | 1.98876773 |
| 90 | Increased CSF protein (HP:0002922) | 1.97565521 |
| 91 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.96241553 |
| 92 | Progressive visual loss (HP:0000529) | 1.94322481 |
| 93 | Cellulitis (HP:0100658) | 1.93966680 |
| 94 | Recurrent fungal infections (HP:0002841) | 1.93329412 |
| 95 | Orchitis (HP:0100796) | 1.93077224 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 1.91906457 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 1.91547229 |
| 98 | Memory impairment (HP:0002354) | 1.91338087 |
| 99 | Periodontitis (HP:0000704) | 1.89945114 |
| 100 | Dementia (HP:0000726) | 1.88362531 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87877439 |
| 102 | Osteolytic defects of the hand bones (HP:0009699) | 1.87877439 |
| 103 | Vasculitis (HP:0002633) | 1.86914824 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 1.86822562 |
| 105 | Bone pain (HP:0002653) | 1.86137408 |
| 106 | Urethral obstruction (HP:0000796) | 1.85385446 |
| 107 | Abnormality of the periventricular white matter (HP:0002518) | 1.85349257 |
| 108 | Deformed sella turcica (HP:0002681) | 1.85052050 |
| 109 | Polyneuropathy (HP:0001271) | 1.84654756 |
| 110 | Xanthomatosis (HP:0000991) | 1.83410732 |
| 111 | Abnormality of the thoracic spine (HP:0100711) | 1.82307157 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 1.79350657 |
| 113 | Restrictive lung disease (HP:0002091) | 1.78275825 |
| 114 | Recurrent viral infections (HP:0004429) | 1.77351690 |
| 115 | Nausea (HP:0002018) | 1.76436182 |
| 116 | Personality changes (HP:0000751) | 1.75758371 |
| 117 | Meningitis (HP:0001287) | 1.75216251 |
| 118 | Conjunctival telangiectasia (HP:0000524) | 1.73422950 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.72264313 |
| 120 | Deep venous thrombosis (HP:0002625) | 1.72049681 |
| 121 | Urticaria (HP:0001025) | 1.70643827 |
| 122 | Global brain atrophy (HP:0002283) | 1.69271402 |
| 123 | Premature loss of primary teeth (HP:0006323) | 1.69039939 |
| 124 | Purpura (HP:0000979) | 1.68781462 |
| 125 | Pulmonary embolism (HP:0002204) | 1.68087983 |
| 126 | Thin bony cortex (HP:0002753) | 1.65257795 |
| 127 | Peritonitis (HP:0002586) | 1.65121822 |
| 128 | Bone cyst (HP:0012062) | 1.63533863 |
| 129 | Arterial thrombosis (HP:0004420) | 1.63165992 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 6.05249209 |
| 2 | BLK | 4.40975255 |
| 3 | ERN1 | 3.24548190 |
| 4 | TYK2 | 3.23848143 |
| 5 | NME2 | 3.10049008 |
| 6 | CSF1R | 2.89996380 |
| 7 | CAMK1D | 2.80707089 |
| 8 | DDR2 | 2.78570842 |
| 9 | GRK7 | 2.66627736 |
| 10 | MAPK15 | 2.56322071 |
| 11 | TBK1 | 2.51836113 |
| 12 | RIPK4 | 2.45929664 |
| 13 | IRAK4 | 2.20650597 |
| 14 | CAMK1G | 2.06725769 |
| 15 | TRIB3 | 2.03961492 |
| 16 | TAOK2 | 2.01277325 |
| 17 | MAP4K1 | 2.00266010 |
| 18 | PRPF4B | 1.92427467 |
| 19 | ACVR1B | 1.84396001 |
| 20 | IRAK3 | 1.83510491 |
| 21 | KIT | 1.80676952 |
| 22 | CDC42BPA | 1.76155878 |
| 23 | EPHB1 | 1.75996284 |
| 24 | PKN2 | 1.75675508 |
| 25 | PAK4 | 1.74777893 |
| 26 | JAK1 | 1.71801467 |
| 27 | TAOK1 | 1.68060693 |
| 28 | MAP3K14 | 1.54224354 |
| 29 | ZAP70 | 1.53146336 |
| 30 | MST1R | 1.52443768 |
| 31 | MAP2K3 | 1.47634171 |
| 32 | PIM2 | 1.47327987 |
| 33 | FES | 1.45392722 |
| 34 | CAMKK2 | 1.44824883 |
| 35 | HCK | 1.42696022 |
| 36 | ABL2 | 1.41970783 |
| 37 | CSK | 1.40593341 |
| 38 | RIPK1 | 1.38443055 |
| 39 | STK10 | 1.35851357 |
| 40 | TESK1 | 1.23264919 |
| 41 | CAMKK1 | 1.20221572 |
| 42 | NEK9 | 1.19438332 |
| 43 | IKBKB | 1.18853222 |
| 44 | JAK2 | 1.17340331 |
| 45 | PTK6 | 1.16084351 |
| 46 | MATK | 1.15115569 |
| 47 | SCYL2 | 1.10509321 |
| 48 | CLK1 | 1.08239265 |
| 49 | IKBKE | 1.07397142 |
| 50 | FGR | 1.04306001 |
| 51 | EPHB2 | 0.95626836 |
| 52 | LCK | 0.95027723 |
| 53 | SYK | 0.94784128 |
| 54 | MOS | 0.94762544 |
| 55 | TESK2 | 0.94752390 |
| 56 | LYN | 0.94341370 |
| 57 | TAOK3 | 0.92078895 |
| 58 | TSSK6 | 0.90933678 |
| 59 | MAP3K3 | 0.89418521 |
| 60 | MAP3K13 | 0.88419344 |
| 61 | PDGFRA | 0.87075386 |
| 62 | MAPK12 | 0.85296393 |
| 63 | EPHA3 | 0.81532745 |
| 64 | TTN | 0.80006437 |
| 65 | BTK | 0.77007913 |
| 66 | SIK2 | 0.72717069 |
| 67 | BMX | 0.69793370 |
| 68 | TGFBR1 | 0.69474159 |
| 69 | BMPR2 | 0.68672036 |
| 70 | TYRO3 | 0.68343856 |
| 71 | TXK | 0.68146075 |
| 72 | CDK6 | 0.67019751 |
| 73 | PRKG2 | 0.64372779 |
| 74 | JAK3 | 0.64345590 |
| 75 | MAP3K10 | 0.64063443 |
| 76 | MAP2K6 | 0.63787429 |
| 77 | EGFR | 0.63751574 |
| 78 | IRAK1 | 0.63395171 |
| 79 | PDK2 | 0.62933576 |
| 80 | DAPK2 | 0.62447818 |
| 81 | IGF1R | 0.62027462 |
| 82 | MAP3K11 | 0.61671314 |
| 83 | ITK | 0.59650627 |
| 84 | ICK | 0.59392048 |
| 85 | MAP3K5 | 0.59066902 |
| 86 | IRAK2 | 0.56895708 |
| 87 | FGFR4 | 0.56648462 |
| 88 | TNK2 | 0.55597334 |
| 89 | PDK1 | 0.55472953 |
| 90 | PAK2 | 0.53651819 |
| 91 | PDPK1 | 0.53586273 |
| 92 | MARK3 | 0.53156942 |
| 93 | PIK3CG | 0.52852156 |
| 94 | MAPKAPK2 | 0.51551846 |
| 95 | RPS6KA4 | 0.50039893 |
| 96 | CAMK4 | 0.48395172 |
| 97 | ARAF | 0.47140880 |
| 98 | GSK3A | 0.46383627 |
| 99 | GRK5 | 0.44369803 |
| 100 | PRKCD | 0.43033803 |
| 101 | EEF2K | 0.42987131 |
| 102 | ADRBK2 | 0.42889324 |
| 103 | FYN | 0.41686497 |
| 104 | LRRK2 | 0.41521168 |
| 105 | GRK6 | 0.41055432 |
| 106 | RPS6KA2 | 0.39362451 |
| 107 | SIK3 | 0.39344448 |
| 108 | LIMK1 | 0.39242049 |
| 109 | MARK2 | 0.39114187 |
| 110 | MAP3K9 | 0.37947645 |
| 111 | FGFR3 | 0.37523513 |
| 112 | PDGFRB | 0.36730412 |
| 113 | ABL1 | 0.36714886 |
| 114 | PRKCH | 0.36058038 |
| 115 | CHUK | 0.35801984 |
| 116 | PRKAA2 | 0.35547833 |
| 117 | HIPK2 | 0.33104491 |
| 118 | MAP3K1 | 0.33015019 |
| 119 | PTK2B | 0.32653960 |
| 120 | RPS6KA6 | 0.32596928 |
| 121 | MAPK7 | 0.32279404 |
| 122 | MAPKAPK3 | 0.32027585 |
| 123 | MAPK4 | 0.31899944 |
| 124 | DMPK | 0.30494857 |
| 125 | LATS2 | 0.30448005 |
| 126 | RET | 0.29904054 |
| 127 | INSR | 0.29532120 |
| 128 | SIK1 | 0.29480259 |
| 129 | TEC | 0.29001286 |
| 130 | PRKD1 | 0.28601671 |
| 131 | PIM1 | 0.27948993 |
| 132 | DAPK3 | 0.27537790 |
| 133 | RPS6KL1 | 0.27340965 |
| 134 | RPS6KC1 | 0.27340965 |
| 135 | MET | 0.25789560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.89489348 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.74089362 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.60245441 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 3.44447003 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.63552214 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54257795 |
| 7 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53731703 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49071113 |
| 9 | * Pertussis_Homo sapiens_hsa05133 | 2.43309812 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.39028624 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.16220344 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94984805 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.81447931 |
| 14 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.72578177 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71319203 |
| 16 | * Prion diseases_Homo sapiens_hsa05020 | 1.66858173 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66545914 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.56189709 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.56037033 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55259250 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.51828663 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50570607 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49005906 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35237963 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26993819 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15852352 |
| 27 | Salmonella infection_Homo sapiens_hsa05132 | 1.12934744 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08822590 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.08140624 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07014016 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04908749 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.01103208 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98715540 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.97835847 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97388279 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93764966 |
| 37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93144593 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 0.85811214 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84216081 |
| 40 | Endocytosis_Homo sapiens_hsa04144 | 0.83967408 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81561751 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 0.78385198 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77723654 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.77627390 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76702745 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.76070440 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74718664 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74202139 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73737506 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.73036843 |
| 51 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72901061 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71380306 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71085874 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67568803 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66796763 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66396007 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65327561 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63176363 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.62360844 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60861433 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60656343 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59728632 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58925618 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.57833919 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57480531 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54035368 |
| 67 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52108451 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50457683 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.48880541 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48868385 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48279646 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47661573 |
| 73 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46309263 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45715908 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45373103 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44690009 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44290308 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44088412 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43878209 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43461206 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41544629 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41453190 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39826124 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38305981 |
| 85 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37583272 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.36591218 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.34104393 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33822015 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.33248326 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33237327 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31898101 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31627774 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31274944 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29687476 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29437059 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.28736757 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28271848 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28247299 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.27399476 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27379584 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.27300537 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.26694563 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.26277845 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26151423 |
| 105 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.24867126 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24141969 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22869142 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22853939 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22518057 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.22134956 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21555463 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20886986 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20813146 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20313792 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20284460 |
| 116 | Allograft rejection_Homo sapiens_hsa05330 | 0.19970448 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.19244925 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.19056788 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.16254586 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.15989643 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.15871525 |

